A novel therapeutic tool for kidney fibrosis
Fibrosis is the neurological disease of the kidneys that causes degeneration of the filtration membrane comprising several tissue layers. Synoviruses (in particular siRNAS) are viruses that can enter and infect blood vessels and causes renal failure. However both siRNA-based therapies and traditional drug treatments based on siRNAs have demonstrated protection against early and advanced pathogenic viral infections. Recently there have been reports of highly therapeutic efficacy against the polyposome parasite Porphyromonas reinhardtii in vitro and in vivo although later clinical efficacy against the malaria parasite P. falciparum is less well-established. Vitisx virus is one of the pathogen that iPS researchers have been able to demonstrate amenable to siRNA-based si research inhibition.